Adaptimmune Therapeutics PLC (ADAP)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -28.528 | -27.095 | -32.115 | -59.06 | -41.124 | -34.342 | -41.444 | -37.241 |
Return on Equity (%) | -37.337 | -37.549 | -39.621 | -72.817 | -55.97 | -57.783 | -114.965 | -187.61 |
Return on Invested Capital (%) | -39.839 | -41.9 | -37.554 | -75.864 | -58.305 | -58.316 | -118.165 | -204.198 |
Operating Margin (%) | -519.622 | -211.252 | -180.612 | -12203.476 | -3282.719 | -2558.123 | -600.262 | -186.684 |
Net Profit Margin (%) | -484.568 | -188.481 | -153.861 | -12225.045 | -3286.812 | -2570.987 | -609.459 | -188.9 |
Book Value Per Share | 0.388 | 0.359 | 0.391 | 0.192 | 0.366 | 0.219 | 0.082 | 0.029 |
Earnings Per Share | -0.162 | -0.127 | -0.146 | -0.217 | -0.14 | -0.169 | -0.168 | -0.084 |
Cash Per Share | 0.374 | 0.15 | 0.109 | 0.08 | 0.061 | 0.16 | 0.109 | 0.106 |
Working Capital Per Share | 0.373 | 0.277 | 0.329 | 0.137 | 0.387 | 0.376 | 0.193 | 0.099 |
Operating Profit Per Share | 0.038 | 0.07 | 0.097 | 0.031 | 0.028 | 0.049 | 0.06 | 0.075 |
EBIT Per Share | -0.174 | -0.143 | -0.172 | -0.217 | -0.14 | -0.168 | -0.165 | -0.083 |
EBITDA Per Share | -0.174 | -0.143 | -0.172 | -0.217 | -0.14 | -0.168 | -0.165 | -0.083 |
Free Cash Flow Per Share | -0.133 | -0.09 | -0.151 | -0.225 | -0.145 | -0.166 | -0.144 | -0.087 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 424,78M | 562,12M | 627,45M | 631M | 928,76M | 937,55M | 987,11M | 1,36B |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 987,11M | 993,7M | 1,35B | 1,36B | 1,36B | 1,53B | 1,53B | 1,53B |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | 3.489 | N/A | N/A | N/A | -844.963 | N/A | N/A |
Net Profit Margin (%) | N/A | 2.176 | N/A | N/A | N/A | -854.227 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 150,97M |
Ratio cours/bénéfice | -1,3 |
Ratio prix/ventes | 2,46 |
Ratio prix/liquidités | 1,03 |
Ratio prix/valeur comptable | 3,76 |
Rendement de dividende | - |
Actions en circulation | 255,88M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | - |
Plus haut sur 52 semaines | - |
Plus bas sur 52 semaines | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales